Researchers developed a consensus-based standardized corticosteroid dosing regimen for patients with childhood-onset systemic lupus erythematosus with lupus nephritis.
Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies
Researchers assessed molecular changes of Tr1 cells through CD46 cytoplasmic tail in patients with lupus nephritis who received intravenous methylprednisone therapy.
Marcus Säemann, MD, talks about the role of SGLT-2 inhibitors and their strong nephroprotective potential that may benefit patients with ANCA-associated vasculitis and lupus nephritis.
Researchers analyzed mortality trends in lupus nephritis in the US from 1999 to 2019 and identified population characteristics associated with mortality.
In a second interim analysis of the AURORA 2 extension study, researchers reported on the effects of voclosporin on lupus nephritis.
An overview of a review paper by Ibrahim Almaghlouth and colleagues highlighting the principles of immunoglobulin measurements and the primary and secondary causes of low immunoglobulin levels in patients with systemic lupus erythematosus.
The aim of the review was to identify and validate principles related to the diagnosis, treatment, and surveillance of lupus nephritis in childhood.
